Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.4K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Hazard Ratio01:12

Hazard Ratio

686
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
686
Hazard Rate01:11

Hazard Rate

474
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
474
Decision Making: P-value Method01:09

Decision Making: P-value Method

7.1K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
7.1K
Framing Effects03:26

Framing Effects

8.0K
Information is everywhere and its presentation—such as how and when items are presented—can impact our perceptions and decisions surrounding the info. This broad concept umbrellas framing effects—influences that occur due to the way information is framed in its appearance, whether it’s purely the order or the specific wording of a message. Let’s take a look at numerous ways in which two versions of something can objectively say the same thing, yet we respond in...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay : A Target Trial Emulation.

Annals of internal medicine·2026
Same author

Respiratory surveillance through point of care molecular testing and its impacts on nursing home RSV, influenza, and SARS-CoV-2 awareness and reporting behavior: a pilot study.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

Invasive E. coli Disease in US Nursing Homes: Brief Report of Case Validation Findings.

Journal of the American Geriatrics Society·2026
Same author

Burden of Invasive Escherichia coli Disease Among Veterans Residing in Community Living Centers.

Journal of the American Medical Directors Association·2025
Same author

Immunologic Evaluation of First and Second Doses of SARS-CoV-2 XBB.1.5 and the KP.2 Monovalent Booster Vaccines in Nursing Home Residents.

Journal of the American Geriatrics Society·2025
Same author

Barriers and Facilitators to Best Practices in Microtransitions in Care in Post-acute and Long-Term Care: A Mixed-Methods Study.

Journal of the American Medical Directors Association·2025
Same journal

Digging Deeper Into the Patient-Driven Payment Model.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Clinical Pharmacist Intervention to Engage Older Adults in Reducing Use of Alprazolam.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Statins: The Burglar of Memory?

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Identifying Cognitive Impairment in an Older Adult Using Two Different Screening Tools.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Management of Primary Sjögren's Syndrome.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
Same journal

Increased Use of Medical Marijuana: Skepticism vs. Evidence.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists·2018
See all related articles

Related Experiment Video

Updated: Mar 20, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.5K

Risk Versus Reward

H Edward Davidson

    The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
    |June 3, 2016
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Conflict Model of Reward-seeking Behavior in Male Rats
    06:11

    A Conflict Model of Reward-seeking Behavior in Male Rats

    Published on: February 20, 2019

    8.0K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.7K

    Related Experiment Videos

    Last Updated: Mar 20, 2026

    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
    13:04

    Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

    Published on: September 19, 2012

    12.5K
    A Conflict Model of Reward-seeking Behavior in Male Rats
    06:11

    A Conflict Model of Reward-seeking Behavior in Male Rats

    Published on: February 20, 2019

    8.0K
    An R-Based Landscape Validation of a Competing Risk Model
    05:37

    An R-Based Landscape Validation of a Competing Risk Model

    Published on: September 16, 2022

    2.7K